Goldman Sachs Beats Profit Estimates on Equities Strength
Goldman Sachs posted Q3 EPS of $17.01, beating the $13.02 consensus, as equities revenue rose 72% to $6.44 billion.
Already have an account? Sign in.
Goldman Sachs posted Q3 EPS of $17.01, beating the $13.02 consensus, as equities revenue rose 72% to $6.44 billion.
Generate Biomedicines receives $30M upfront in a deal with Zealand Pharma to advance AI protein candidates for obesity, up to $1.2B total.
Early Phase 1 data for Biomea’s oral GLP-1 showed limited weight reduction versus expectations, leading investors to sell the stock and management to seek a partner.
CEO Dickerson expressed strong confidence in AI-driven growth but stopped short of a firm wafer fab equipment forecast amid factory and supply limits.
Be the first to know when deals break, stocks move, or biotech headlines hit.